TD Asset Management
BCYC

TD Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

TD Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Hold
91,992
– – ﹤0.01% 1188
2026
Q1 		$427K Sell
91,992
-56,000
-38% -$320K ﹤0.01% 1179
2025
Q4 		$1.05M Sell
147,992
-30,100
-17% -$222K ﹤0.01% 1092
2025
Q3 		$1.38M Sell
178,092
-15,000
-8% -$113K ﹤0.01% 1038
2025
Q2 		$1.34M Hold
193,092
– – ﹤0.01% 1023
2025
Q1 		$1.64M Sell
193,092
-22,924
-11% -$270K ﹤0.01% 1008
2024
Q4 		$3.02M Sell
216,016
-5,400
-2% -$116K ﹤0.01% 893
2024
Q3 		$5.14M Buy
221,416
+124,230
+128% +$2.87M ﹤0.01% 795
2024
Q2 		$1.97M Buy
97,186
+42,200
+77% +$953K ﹤0.01% 1004
2024
Q1 		$1.37M Buy
54,986
+19,800
+56% +$421K ﹤0.01% 1113
2023
Q4 		$636K Sell
35,186
-46,600
-57% -$771K ﹤0.01% 1267
2023
Q3 		$1.64M Buy
81,786
+58,200
+247% +$1.33M ﹤0.01% 1011
2023
Q2 		$602K Hold
23,586
– – ﹤0.01% 1230
2023
Q1 		$502K Hold
23,586
– – ﹤0.01% 1263
2022
Q4 		$698K Buy
23,586
+8,000
+51% +$215K ﹤0.01% 1215
2022
Q3 		$370K Hold
15,586
– – ﹤0.01% 1342
2022
Q2 		$262K Sell
15,586
-13,500
-46% -$285K ﹤0.01% 1363
2022
Q1 		$1.28M Sell
29,086
-2,500
-8% -$117K ﹤0.01% 1192
2021
Q4 		$1.92M Buy
+31,586
New +$1.74M ﹤0.01% 1143

Other funds holding BCYC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FPC
Flax Pond Capital Falmouth, Massachusetts $127M AUM
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

TD Asset Management's BCYC Position: Q2 2026 in Review

TD Asset Management held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 91,992 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

TD Asset Management first reported a position in BCYC in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.14M in Q3 2024. 55 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • TD Asset Management held 91,992 shares of Bicycle Therapeutics worth $390K as of Q2 2026.
  • TD Asset Management left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1188 holding.
  • TD Asset Management first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • TD Asset Management's Bicycle Therapeutics position peaked at $5.14M in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.